Drug Firms Pulling Out Decision from Research into Brain Disorders that will Affect Many Severely

/brain-disordersBrain disorders were definitely not less troubling for many families that a new problem has arisen to make the things more complicated for the people. This time drug firms have lead the threat as they have decided to pull out from the researches regarding brain disorder, which can definitely affect many severely and moreover, will also have a big financial impact on the society.

CHMP Approve New Drugs

CHMP Approve New DrugsReports have suggested that European Medicines Agency’s Committee for Medicinal Products for Human Use has been approved. So this is good news for companies like GlaxoSmithKline, Merck & Co, Bristol-Myers Squibb and Amgen, as well as Astellas and Biogen Idec.

$3.4 B settlement to be faced by Glaxo

Glaxo-SmithKlineIt has been reported that due to its anti-diabetic drug called Avandia, a multi-district litigation amounting to an estimated $3.4 billion, will be faced by GlaxoSmithKline.

Reports also state that in different states of America, a number of pending litigations against Avandia have been filed. It is suppose to be an oral anti-diabetic agent which acts primarily by increasing insulin sensitivity.

Cheryl Eckard's lengthy tour

Cheryl Eckard's lengthy tourIn 2002, drug maker GlaxoSmithKline PLC had sent across quality-assurance managers, Cheryl Eckard, to Puerto Rico to aid in cleaning the heap of mess that gathered around its biggest manufacturing plants. U. S. authorities claimed for certain violations, which aimed at contaminated ointment implemented for treating skin infections on children.

Capacity for elephantiasis drug production to be stepped up

Capacity for elephantiasis drug production to be stepped upA top company executive of British drug maker GlaxoSmithKline, GSK, said that at the company’s manufacturing facility in Nasik and Cape Town, an attempt will be made to increase the capacity to make a drug for the treatment of elephantiasis.

GSK at its production units in Nasik and Cape Town makes albendazole that is used by about 120 million people across the world.

FDA Voted to Keep Avandia in the Markets

FDA Voted to Keep Avandia in the MarketsAfter the emergence of more controversial information of Avandia that it increasing the chances of heart diseases, 20 out of 33 of the U. S. Food and Drug Administration experts voted, on Wednesday, in favor of the GlaxoSmithKline's diabetes drug staying available on the markets, without any restrictions.